导航模糊的边界:神经病理学变化与阿尔茨海默病的临床症状,及其对遗传学研究的影响
Catarina Xavier1, Nádia Pinto1,2,3
1i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Journal of Alzheimer's disease : JAD
|February 16, 2025
概括
科学家们审查了阿尔茨海默病 (AD) 遗传研究,发现最近的全基因组关联研究 (GWAS) 中较不严格的诊断方法可能会阻碍遗传发现. 神经病理学确认对于可靠的AD研究至关重要.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 医学研究方法学 医学研究方法学
背景情况:
- 几十年的研究试图了解阿尔茨海默病 (AD) 的遗传基础.
- 全基因组关联研究 (GWAS) 越来越多地利用更大的样本大小来增强统计能力.
- 在AD研究数据库中诊断标准的质量和一致性对于准确的遗传关联发现至关重要.
研究的目的:
- 以回顾评估阿尔茨海默病的杰出GWAS.
- 评估诊断质量,表型,样本年龄和人口来源对GWAS结果的影响.
- 强调神经病理学确认在阿尔茨海默病研究中的重要性.
主要方法:
- 显著的阿尔茨海默病全基因组关联研究的回顾性分析.
- 评估诊断方法 (临床与神经病理) 及其准确性.
- 调查混因素,包括表型,样本供体年龄和人口来源.
主要成果:
- 在最近的,更大的GWAS中观察到,诊断标准越来越不严格的趋势.
- 不一致的诊断方法和包含混杂的并发症可能会掩盖真正的遗传关联.
- 阿尔茨海默病的临床诊断可能与神经病理学确认有很大差异,这会影响研究的有效性.
结论:
- 最近阿尔茨海默氏症的诊断标准较宽松的GWAS可能限制了相关遗传变异的发现.
- 研究数据库中的表型异质性和混因素可能会导致结果偏差.
- 对阿尔茨海默病的神经病理学确认对于强大的遗传研究和防止误导性结论至关重要.
相关概念视频
Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Human Genetics
522
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
522
Alzheimer's Disease: Treatment
150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K


